When Pain, Examination, Blood Tests and Imaging Disagree
A respectful framework for persistent symptoms: active inflammation, structural problems, mechanical load and altered pain processing.
All chapters in this collection
Understanding the diagnosis
- 1. Peripheral SpA, Undifferentiated SpA and a Working Diagnosis
- 2. Joints, Entheses and Dactylitis: Understanding the Peripheral Pattern
- 3. How the Diagnosis Is Built
- 4. New Symptoms: What Changes the Picture and When Not to Wait
Tests and imaging
- 5. Blood Tests and HLA-B27: What They Can and Cannot Tell You
- 6. Ultrasound, MRI, X-ray and Joint Aspiration: Choosing the Right Test
Treatment decisions
- 7. What Are We Actually Trying to Improve?
- 8. NSAIDs, Local Treatment and Conventional DMARDs
- 9. When Targeted Therapy Enters the Discussion
Daily life and follow-up
- 10. Movement, Feet, Hands, Work and Everyday Load
- 11. How Do We Know Treatment Is Working?
- 12. Pregnancy, Infection, Surgery and Other Medical Conditions
When the picture changes
- 13. Why the Diagnosis May Change
- 14. When Pain, Examination, Blood Tests and Imaging Disagree
- 15. Remission, Treatment Reduction and Long-Term Outlook
Research and future care
You can be in significant pain while a blood test is normal. An image can remain abnormal after inflammation has improved. A joint count can improve while walking remains difficult. These situations do not make your symptoms less real. They mean that the different pieces of information need to be connected carefully.
Each measure sees a different part of the problem
Pain is your experience. Examination identifies findings such as swelling, tenderness, restricted movement or weakness. Blood markers reflect systemic signals and may be uninformative in some individuals. Imaging shows selected tissues at one point in time and may capture old structural changes as well as current activity.
These measures were never interchangeable. Disagreement is a reason to ask a more specific question, not to choose whichever result happens to support the preferred conclusion. The timing of treatment, fluctuations in symptoms and the body region examined may all matter.
First possibility: inflammation is still active
Normal CRP does not exclude active peripheral disease. A focused examination may identify synovitis, dactylitis or an inflammatory attachment problem that explains the limitation. Ultrasound or another targeted investigation may help when the clinical question remains unresolved.
However, a nonspecific imaging abnormality is not automatically proof of ongoing immune inflammation. The exact finding, its location and the clinical context need review. A useful discussion explains what supports active disease and what remains uncertain.
Second possibility: a structural or mechanical consequence
A joint can remain stiff or painful because its structure or movement has changed. Tendon weakness, altered gait, loss of conditioning or an unrelated degenerative problem can also affect function. Suppressing inflammation does not instantly restore strength or reverse every established change.
These contributors may respond to rehabilitation, task adaptation, local measures or another targeted approach. They still deserve treatment. Identifying a mechanical component should lead to a plan, not to the conclusion that nothing can be done.
Third possibility: more than one disease is present
SpA does not protect someone from osteoarthritis, crystal arthritis, nerve compression, injury or infection. A symptom with a new location, timing or quality may require a fresh assessment rather than being added automatically to the old diagnosis.
The same person can have well-controlled inflammatory arthritis and a separate painful disorder. In that situation, escalating immune treatment may add risk without addressing the main source of current disability. The aim is to identify which problem is active now.
Fourth possibility: altered pain processing contributes
The nervous system can become more sensitive to pain. Clinicians may use terms such as nociplastic pain or central sensitization when that mechanism contributes; fibromyalgia is one clinical condition in which widespread pain, fatigue and sleep disturbance may occur.
This does not mean that pain is imagined, voluntarily produced or explained simply by anxiety. It also does not mean that inflammatory disease cannot coexist. A pain-processing contribution should be assessed on positive clinical features, not assigned automatically because one test was normal.
Treatment may include a carefully adapted activity program, work on sleep, selected medicines and psychological or behavioral pain-management approaches. Such approaches aim to change the burden of pain and improve function. They do not require you to agree that the original inflammatory diagnosis was false.
Several mechanisms can be active together
The categories are not competing identities. A person may have residual synovitis, a mechanically overloaded foot and disrupted sleep at the same time. A useful plan can address more than one contributor without asking one treatment to do every job.
This also explains why improvement may be uneven. Swelling can settle before strength returns. Sleep may remain poor after a flare ends. A painful tendon may need progressive rehabilitation even after systemic disease control improves. The plan should state what is expected to change and when it will be reviewed.
How to make the next appointment productive
Describe where symptoms occur, what provokes them, whether visible swelling returns and which tasks remain difficult. Bring the timing of medicine changes, relevant images and the actual reports. Ask whether the findings were measured during the same phase of illness.
Useful questions include: “What supports active inflammation now? Which findings suggest another contributor? Would an additional test change treatment? What is the plan for the symptoms that immune treatment may not address?” You should not have to choose between being believed and having a careful differential diagnosis.
Pain & Fatigue materials provide a related route when appropriate. For your own collection, return to tracking treatment response and adapting everyday load. New urgent symptoms still follow the urgent-care guidance, regardless of a previous explanation for chronic pain.
Sources and further reading
- MedlinePlus: C-reactive protein test
- DEUS: Ultrasound features of enthesitis in spondyloarthritis, 2024
- RadiologyInfo, ACR/RSNA: Musculoskeletal ultrasound
- RadiologyInfo, ACR/RSNA: Musculoskeletal MRI
- NIAMS: Fibromyalgia—diagnosis, treatment and steps to take
- NIAMS: Osteoarthritis—diagnosis, treatment and steps to take